Branded

The Food and Drug Administration has approved Keytruda, Merck's anti-PD-1 therapy, as a single agent for the treatment of some patients with advanced endometrial carcinoma.

The approval is the first indication for Rinvoq in gastroenterology, the company said.

Lynparza is now approved as an adjuvant treatment for patients with germline BRCA-mutated HER2-negative high risk early breast cancer.

Carvykti provides a treatment for adults with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody.

Endo’s Par Sterile Products business is offering Vasostrict, vasopressin injection, in ready-to-use 100 ml premix bottles.

Moving forward Akorn said it will invest in its facilities and targeted avenues of growth, such as its human generics and animal care businesses.

Nalmefene, expected to be available by mid-2022, is indicated for the complete or partial reversal of opioid drug effects.

Cortrophin Gel is indicated for the treatment of certain chronic autoimmune disorders, including acute exacerbations of multiple sclerosis and rheumatoid arthritis and excess urinary protein due to nephrotic syndrome.